Doximity, Inc. (DOCS) is a Medical - Healthcare Information Services company in the Healthcare sector, currently trading at $22.25. It has a SharesGrow Score of 88/100, indicating a strong investment profile with 6 out of 7 criteria passed.
SharesGrow calculates the intrinsic value of DOCS = $46.95 (+111% from the current price, the stock appears undervalued). Analyst consensus target is DOCS = $46 (+106.2% upside).
Valuation: DOCS trades at a trailing Price-to-Earnings (P/E) of 16.5 (S&P 500 average ~25) with a forward Price/Earnings-to-Growth (PEG) of 1.52.
Financials: revenue is $570M, +18.5%/yr average growth. Net income is $223M, growing at +18.3%/yr. Net profit margin is 39.1% (strong). Gross margin is 90.2% (+1.8 pp trend).
Balance sheet: total debt is $12M against $1.1B equity (Debt-to-Equity (D/E) ratio 0.01, conservative). Current ratio is 6.97 (strong liquidity). Debt-to-assets is 1%. Total assets: $1.3B.
Analyst outlook: 17 / 22 analysts rate DOCS as buy (77%) — strong consensus.
SharesGrow 7-Criteria breakdown: Value 83/100 (Pass), Growth 80/100 (Pass), Past 100/100 (Pass), Health 100/100 (Pass), Moat 66/100 (Partial), Future 85/100 (Pass), Income 100/100 (Pass).
